demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID-19 severe or critically
COVID 19 outpatients
nirmatrelvir / ritonavir (Paxlovid) EPIC-HR

0 studies excluded by filtering options 0